259 related articles for article (PubMed ID: 8118815)
1. Inhibitory effects of tumor invasion-inhibiting factor 2 and its conjugate on disseminating tumor cells.
Isoai A; Goto-Tsukamoto H; Yamori T; Oh-hara T; Tsuruo T; Silletti S; Raz A; Watanabe H; Akedo H; Kumagai H
Cancer Res; 1994 Mar; 54(5):1264-70. PubMed ID: 8118815
[TBL] [Abstract][Full Text] [Related]
2. Tumor invasion-inhibiting factor 2: primary structure and inhibitory effect on invasion in vitro and pulmonary metastasis of tumor cells.
Isoai A; Giga-Hama Y; Shinkai K; Mukai M; Akedo H; Kumagai H
Cancer Res; 1992 Mar; 52(6):1422-6. PubMed ID: 1311631
[TBL] [Abstract][Full Text] [Related]
3. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
[TBL] [Abstract][Full Text] [Related]
4. A potent anti-metastatic activity of tumor invasion-inhibiting factor-2 and albumin conjugate.
Isoai A; Goto-Tsukamoto H; Murakami K; Akedo H; Kumagai H
Biochem Biophys Res Commun; 1993 Apr; 192(1):7-14. PubMed ID: 8476436
[TBL] [Abstract][Full Text] [Related]
5. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor invasion and metastasis by peptidic mimetics of Arg-Gly Asp (RGD) derived from the cell recognition site of fibronectin.
Fujii H; Nishikawa N; Komazawa H; Orikasa A; Ono M; Itoh I; Murata J; Azuma I; Saiki I
Oncol Res; 1996; 8(9):333-42. PubMed ID: 8979267
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells.
Schultz RM; Silberman S; Persky B; Bajkowski AS; Carmichael DF
Cancer Res; 1988 Oct; 48(19):5539-45. PubMed ID: 3416307
[TBL] [Abstract][Full Text] [Related]
8. Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.
Lozonschi L; Sunamura M; Kobari M; Egawa S; Ding L; Matsuno S
Cancer Res; 1999 Mar; 59(6):1252-8. PubMed ID: 10096556
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of experimental pulmonary metastasis of mouse colon adenocarcinoma 26 sublines by a sialic acid:nucleoside conjugate having sialyltransferase inhibiting activity.
Kijima-Suda I; Miyamoto Y; Toyoshima S; Itoh M; Osawa T
Cancer Res; 1986 Feb; 46(2):858-62. PubMed ID: 3753583
[TBL] [Abstract][Full Text] [Related]
10. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals.
Hidvégi M; Ráso E; Tömösközi-Farkas R; Paku S; Lapis K; Szende B
Anticancer Res; 1998; 18(4A):2353-8. PubMed ID: 9703878
[TBL] [Abstract][Full Text] [Related]
11. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of vasoactive intestinal polypeptide (VIP) on experimental liver metastasis by murine colon 26-L5 carcinoma cells.
Ogasawara M; Murata J; Ayukawa K; Saiki I
Oncol Res; 1998; 10(7):361-70. PubMed ID: 10063970
[TBL] [Abstract][Full Text] [Related]
13. Antimetastatic effect of an orally active heparin derivative on experimentally induced metastasis.
Lee DY; Park K; Kim SK; Park RW; Kwon IC; Kim SY; Byun Y
Clin Cancer Res; 2008 May; 14(9):2841-9. PubMed ID: 18451252
[TBL] [Abstract][Full Text] [Related]
14. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
15. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
Reinmuth N; Liu W; Ahmad SA; Fan F; Stoeltzing O; Parikh AA; Bucana CD; Gallick GE; Nickols MA; Westlin WF; Ellis LM
Cancer Res; 2003 May; 63(9):2079-87. PubMed ID: 12727823
[TBL] [Abstract][Full Text] [Related]
16. Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma.
Langley RR; Carlisle R; Ma L; Specian RD; Gerritsen ME; Granger DN
Microcirculation; 2001 Oct; 8(5):335-45. PubMed ID: 11687945
[TBL] [Abstract][Full Text] [Related]
17. Suppression of experimental lung colonization of a metastatic variant of murine colon adenocarcinoma 26 by a monoclonal antibody 8F11 inhibiting tumor cell-induced platelet aggregation.
Sugimoto Y; Watanabe M; Oh-hara T; Sato S; Isoe T; Tsuruo T
Cancer Res; 1991 Feb; 51(3):921-5. PubMed ID: 1988132
[TBL] [Abstract][Full Text] [Related]
18. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
19. Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma.
Nakajima M; Hayashi K; Egi Y; Katayama K; Amano Y; Uehata M; Ohtsuki M; Fujii A; Oshita K; Kataoka H; Chiba K; Goto N; Kondo T
Cancer Chemother Pharmacol; 2003 Oct; 52(4):319-24. PubMed ID: 12783205
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action.
Inokuchi J; Jimbo M; Momosaki K; Shimeno H; Nagamatsu A; Radin NS
Cancer Res; 1990 Oct; 50(20):6731-7. PubMed ID: 2145065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
